CIK 0001601485
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Elicio Therapeutics, Inc.
Sign in to watch- Ticker
- ELTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113430072
- Phone
- +1 857-209-0050
- Business address
- 451 D STREET, 5TH FLOOR, BOSTON, MA, 02210
- Former names
- Angion Biomedica Corp.
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Director gave up 32,082 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Open-market sale Venkatesan Jay sold 159,177 shares at $16.00 ($2,546,832)
- 4/A Open-market sale Director sold 246,720 shares at $16.00 ($3,947,520)
- 4 Open-market buy Venkatesan Jay bought 11,313 shares at $1.25 ($14,103)
- 4 Open-market buy Venkatesan Jay bought 82,200 shares at an average $1.23 ($101,428)
- 4 Open-market buy Director bought 9,383 shares at an average $1.16 ($10,925)
Page 4 of 7 · 140 filings